Confirmation test about improvements of intestinal environment and immune function by test-food intake
- Conditions
- Healthy male/female adults
- Registration Number
- JPRN-UMIN000041529
- Lead Sponsor
- CPCC Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
(1) Subjects with some kind of medical treatment continuously. (2) Subjects who have used some kind of medicine that might affect their intestine-regulating and immune functions. (3) Subjects who have used the following foods that might affect their intestine-regulating and immune functions; health-specific, functional, supplemental, health foods. (4) All through this trial, subjects who have any difficulty in refraining from having denying/restricting foods. (5) Pregnant or possibly pregnant women, or lactating ones. (6) Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs. (7) Subjects with excessive alcohol intake. (8) Subjects with extremely irregular life rhythms, and subjects with midnight work or irregular shift work. (9) Subjects with previous medical history of drug and/or food allergy (especially in a soybean). (10) Subjects who are now under the other clinical tests with some kind of medicine/food, or participated those tests within four weeks after the current trial. (11) Subjects who donated over 200 mL of their whole blood and/or blood components within a month to the current trial. (12) Male subjects who donated over 400 mL of their whole blood within the last three months to the current trial. (13) Female subjects who donated over 400 mL of their whole blood within the last four months to the current trial. (14) Male subjects who will be collected over 1200 mL in total of their blood within the last twelve months, after adding the planned sampling blood amounts in this trial. (15) Female subjects who will be collected over 800 mL in total of their blood within the last twelve months, after adding the planned sampling blood amounts in this trial. (16) Others who have been determined as ineligible for participation, according to the principal/sub investigator's opinions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method